Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
AMRUTANJAN
₹518.70
₹516.65
₹539.70
₹482.80
₹790.95
Markets Today
Historical Performance
As of 25-08-2026 00:55, Amrutanjan Health Care Ltd. share price today is ₹0, with a change of ₹-536.35 (-100.00%) from the previous close of ₹536.35. The stock opened at ₹539.7 and traded between ₹516.65 and ₹539.7, with a total traded volume of 63584 shares. The company has a market capitalization of ₹1550.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹790.95 and ₹482.8, respectively.
Amrutanjan Health Care Ltd. valuation metrics include a P/E ratio of 28.7, and book value of ₹4.10. Profitability indicators show ROE of 15.64% along with a dividend yield of 0.9%. Amrutanjan Health Care Ltd. has reported revenue of ₹511.48 Cr and net profit of ₹53.97 Cr.
Amrutanjan Health Care Ltd. technical indicators include Day RSI at 58.47, Day MFI at 77.55, Day ADX at 17.32. Additional indicators include Commodity Channel Index (CCI) at 135.4 and Williams %R at -20.19. Momentum indicators show Day MACD at -5.24, Day MACD Signal Line at -7.76, DayATR at 18.93. Rate of Change indicators for Amrutanjan Health Care Ltd. include ROC125 at -12.33 and ROC21 at 3.18.
Exponential moving averages include EMA5 at ₹515.4, EMA10 at ₹511.4, EMA12 at ₹511.6, EMA20 at ₹514.2, EMA26 at ₹516.8, EMA50 at ₹526.2, EMA100 at ₹544.2, EMA200 at ₹578.5. Simple moving averages include SMA5 at ₹507.4, SMA10 at ₹507.4, SMA20 at ₹512.5, SMA30 at ₹519.2, SMA50 at ₹528.6, SMA100 at ₹539.7, SMA150 at ₹555.5, SMA200 at ₹586.8.
Support levels for Amrutanjan Health Care are placed at First Support ₹523.23, Second Support ₹510.12, Third Support ₹497.73. Resistance levels are seen at First Resistance ₹548.73, Second Resistance ₹561.12, Third Resistance ₹574.23. Amrutanjan Health Care Ltd. shareholding pattern shows promoter holding at 46.52%, FII holding at 2.44%, DII holding at 0%, public holding at 38.72%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 102.97 | 149.77 | 141.04 | 117.70 | 94.05 |
| Operating Expense | 96.73 | 124.23 | 115.87 | 101.17 | 85.60 |
| Operating Profit | 6.24 | 25.54 | 25.17 | 16.53 | 8.45 |
| Depreciation | 1.92 | 1.61 | 1.62 | 1.56 | 1.53 |
| Interest | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 |
| Tax | 1.70 | 4.82 | 6.91 | 5.25 | 2.98 |
| Net Profit | 4.37 | 16.19 | 19.45 | 13.96 | 8.31 |
₹518.70
↗ Bullish Moving Average
11
↘ Bearish Moving Average
5
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 46.5 | 46.5 | 46.5 | 46.5 | 46.5 | 46.5 |
| FII | 2.3 | 2.4 | 2.4 | 2.3 | 2.2 | 2.4 |
| DII | 11.4 | 12.7 | 12.9 | 13 | 12.6 | 12.3 |
| Public | 39.8 | 38.3 | 38.2 | 38.2 | 38.6 | 38.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.77 L | 6.53 L | 42.43% |
| Week | 4.08 L | 6.93 L | 58.84% |
| 1 Month | 1.36 L | 2.24 L | 60.48% |
| 6 Month | 49.7 K | 78.8 K | 63.07% |
Companies with no Debt
Benjamin Graham Value Screen
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Relative Outperformance versus Industry over 1 Week
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 11 Sep, 2026 | 2.9 | FINAL | 11 Sep, 2026 | Equity Share |
| 06 Feb, 2026 | 1 | INTERIM | 07 Feb, 2026 | Equity Share |
| 18 Nov, 2025 | 1 | INTERIM | 18 Nov, 2025 | Equity Share |
| 16 Sep, 2025 | 2.6 | FINAL | 16 Sep, 2025 | Equity Share |
| 18 Feb, 2025 | 1 | INTERIM | 18 Feb, 2025 | Equity Share |
| 22 Nov, 2024 | 1 | INTERIM | 22 Nov, 2024 | Equity Share |
| 13 Sep, 2024 | 2.6 | FINAL | Equity Share | |
| 20 Feb, 2024 | 1 | INTERIM | 20 Feb, 2024 | Equity Share |
| 23 Nov, 2023 | 1 | INTERIM | 23 Nov, 2023 | Equity Share |
| 14 Sep, 2023 | 2.6 | FINAL | 14 Sep, 2023 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹526.25 | ₹6.55 | ₹205.20 | ₹15.46 | ₹100.52 |
| % Change | -2.70% | 4.97% | 4.81% | 8.26% | 4.99% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹305.93 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹16.01 |
| PE TTM | 115.10 | -0.30 | 51.80 | 2.40 | 32.50 |
| 1 Year Return | 37.97 | 524 | 55.39 | 56.92 | 8.81 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 0.77 |
Sigachi Industries Ltd.
₹ 30.45
+1.33%
Windlas Biotech Ltd.
₹ 988.00
-0.56%
Vineet Laboratories Ltd.
₹ 37.00
-2.14%
Solara Active Pharma Sciences Ltd.
₹ 628.00
+1.80%
Zim Laboratories Ltd.
₹ 124.16
-0.70%
Medico Remedies Ltd.
₹ 42.09
-1.31%
Dishman Carbogen Amcis Ltd.
₹ 173.00
-0.31%
Lasa Supergenerics Ltd.
₹ 7.33
+1.81%
Haleos Labs Ltd.
₹ 1500.00
+2.39%
Advanced Enzyme Technologies Ltd.
₹ 302.20
+0.73%
Bajaj Healthcare Ltd.
₹ 322.00
+0.00%
Ortin Global Ltd.
₹ 15.26
-3.96%
Brooks Laboratories Ltd.
₹ 61.70
+2.83%
RPG Life Sciences Ltd.
₹ 2638.00
+0.05%
Bafna Pharmaceuticals Ltd.
₹ 254.55
+4.99%
Alpa Laboratories Ltd.
₹ 61.20
-2.47%
SMS Pharmaceuticals Ltd.
₹ 354.00
-0.73%
Nectar Lifesciences Ltd.
₹ 10.80
+3.15%
Mangalam Drugs and Organics Ltd.
₹ 30.44
+9.97%
Indoco Remedies Ltd.
₹ 220.00
-2.78%
Ind-Swift Laboratories Ltd.
₹ 325.35
-1.29%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
-0.33%
Panacea Biotec Ltd.
₹ 406.50
-1.12%
Medicamen Biotech Ltd.
₹ 234.00
-4.31%
Themis Medicare Ltd.
₹ 120.50
+13.53%
By signing up I certify terms, conditions & privacy policy